Net Margin - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

Net Margin
GlaxoSmithKline PLC

12.8%
Current
27%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.8%
=
Net Income
4B
/
Revenue
31.4B

Net Margin Across Competitors

Country UK
Market Cap 79.2B USD
Net Margin
13%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 843.2B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 385.8B USD
Net Margin
44%
Country US
Market Cap 278.3B USD
Net Margin
22%
Country CH
Market Cap 206.1B CHF
Net Margin
20%
Country UK
Market Cap 240.2B USD
Net Margin
13%
Country CH
Market Cap 191.2B CHF
Net Margin
33%
Country US
Market Cap 162B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for GlaxoSmithKline PLC.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.8%
=
Net Income
4B
/
Revenue
31.4B
What is the Net Margin of GlaxoSmithKline PLC?

Based on GlaxoSmithKline PLC's most recent financial statements, the company has Net Margin of 12.8%.